BHC
Bausch Health Companies Inc
Bausch Health Companies Inc historical holders
total: 7
Eagle Capital Management Bausch Health Companies Inc transactions over time
- Total transactions:
- 8
- New positions:
- 4
- Sold out:
- 4
- Held since:
- 2021 Q1
- Held for:
- 2 quarters
- Latest activity:
- 2021 Q3
Eagle Capital Management has been an institutional investor in Bausch Health Companies Inc (BHC) since 2018 Q3. According to 2026 Q1 report, Eagle Capital Management doesn't hold any shares. The fund/company first acquired BHC in 2018 Q3, initially purchasing 8,600 shares. Eagle Capital Management later completely sold out the position and reinvested in BHC again in 2021 Q1. Since the initial investment, Eagle Capital Management has made 7 more transactions in this position.
When did Eagle Capital Management exit their BHC position?
Eagle Capital Management no longer holds Bausch Health Companies Inc (BHC). They sold off their entire position in 2021 Q3, closing out an investment that began in 2018 Q3.
When did Eagle Capital Management first invest in BHC?
Eagle Capital Management first invested in Bausch Health Companies Inc (BHC) in 2018 Q3 at the reported quarter-end price of $25.70 per share, acquiring 8,600 shares in their initial purchase.
What is Eagle Capital Management's average cost basis for BHC?
Based on historical transaction data, Eagle Capital Management's estimated cost basis for Bausch Health Companies Inc (BHC) is approximately $31.74 per share. This represents their average reported price* across all buy transactions.
Has Eagle Capital Management reinvested in BHC after selling?
Yes, Eagle Capital Management has shown renewed interest in Bausch Health Companies Inc (BHC). After completely selling their position, they reinitiated an investment in 2021 Q1, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $31.74
- Weighted AVG sell price:
- $29.30
BHC transactions history by Eagle Capital Management
8 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q3
|
0.00%
|
0
|
$29.30
|
|
-100% (-8,600)
|
-0%
|
|
2021 Q1
|
0.00%
|
8,600
|
$31.74
|
$273,000
|
new
|
+0%
|
|
2020 Q1
|
0.00%
|
$29.88
|
-100% (-8,600)
|
|||
|
2019 Q4
|
0.00%
|
$29.88
|
new
|
|||
|
2019 Q3
|
0.00%
|
$25.23
|
-100% (-8,600)
|
|||
|
2019 Q1
|
0.00%
|
$24.65
|
new
|
|||
|
2018 Q4
|
0.00%
|
$25.70
|
-100% (-8,600)
|
|||
|
2018 Q3
|
0.00%
|
$25.70
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.